Table 3.

Antidiabetic therapy in HCC, cirrhotic patients and in Controls with type 2 diabetes mellitus n (%)

	Metformin	Sulfonylureas	Insulin
Total
HCC	14 (15.9)a	74 (84.1)d	57 (39.6)g
Controls	15 (31.2)b	33 (68.8)e	14 (20.9)h
LC	58 (70.7)c	24 (29.3)f	62 (43.0)i

^a,d vs ^b,eP = 0.04; ^a,d vs ^c,fP < 0.001; ^b,e vs ^c,fP < 0.001;

^g vs

^hP < 0.025;

ⁱ vs ^hP = 0.007.